iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionHartland & Co., LLC
Latest Disclosed Ownership2,283 shares
Latest Disclosed Value $ 385,432
Hartland & Co., LLC reports 198.82% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 6, 2026 - Hartland & Co., LLC filed a 13F-HR form disclosing ownership of 2,283 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $385,432 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 764 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 198.82% during the quarter. The current value of the position is $299,187 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,283 1,519 198.82 385 200.78 0.0035
2026-02-09 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 764 -2 -0.26 129 16.36 0.0016
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 766 0 0.00 111 14.58 0.0015
2025-08-08 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 766 -151 -16.47 97 -17.95 0.0014
2025-05-13 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 917 -85 -8.48 117 -11.36 0.0018
2025-02-10 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,002 0 0.00 132 -8.97 0.0020
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,002 1 0.10 146 5.84 0.0023
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,001 149 17.49 137 20.18 0.0023
2024-05-14 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 852 -263 -23.59 115 -24.50 0.0057
2024-02-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,115 0 0.00 152 11.03 0.0080
2023-11-13 2023-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 1,115 360 47.68 136 43.16 0.0084
2023-11-07 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,115 360 136 0.0075
2023-08-07 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 755 0 0.00 96 -2.06 0.0058
2023-05-09 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 755 0 0.00 98 -2.02 0.0071
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 755 105 16.15 99 30.26 0.0078
2022-11-15 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 650 215 49.43 76 49.02 0.0070
2022-08-12 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 435 -200 -31.50 51 -38.55 0.0040
2022-05-04 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 635 0 0.00 83 -14.43 0.0056
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 635 200 45.98 97 38.57 0.0066
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 435 0 0.00 70 -1.41 0.0052
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 435 0 0.00 71 9.23 0.0055
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 435 0 0.00 65 -1.52 0.0054
2021-02-11 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 435 -22 -4.81 66 6.45 0.0060
2020-11-12 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 457 0 0.00 62 0.00 0.0066
2020-08-11 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 457 22 5.06 62 31.91 0.0072
2020-05-14 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 435 435 47 0.0068
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.